Organon (OGN) Total Debt (2020 - 2026)
Organon (OGN) posted quarterly Total Debt of $8.6 billion for Q2 2026, down 4.26% year-over-year from $9.0 billion in Q2 2025, and little changed on a QoQ basis from $8.6 billion in Q1 2026.
Organon (OGN) Total Debt (2020 - 2026) Analysis & Trends
Organon has reported Total Debt for 7 years, with the latest figure at $8.6 billion in Q2 2026.
- Total Debt for Q2 2026 came in at $8.6 billion, down 4.26% year-over-year; the trailing twelve-month figure through Jun 2026 was $8.6 billion (down 4.26% YoY), and the FY2025 annual result was $8.7 billion, down 2.7% from the prior year.
- Total Debt held at $8.6 billion in Q2 2026, from $8.6 billion in the prior quarter.
- Over five years, Total Debt peaked at $9.1 billion in Q1 2022 and troughed at $8.6 billion in Q1 2026.
- A 5-year average of $8.8 billion and a median of $8.7 billion in 2023 frame the typical range for Total Debt.
- The largest YoY upside for Total Debt was 499.28% in 2022 against a maximum downside of 6.77% in 2022.
- A 5-year view of Total Debt shows it stood at $8.9 billion in 2022, then dropped by 1.8% to $8.8 billion in 2023, then grew by 1.6% to $8.9 billion in 2024, then declined by 2.7% to $8.7 billion in 2025, then declined by 0.38% to $8.6 billion in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $8.6 billion in Q2 2026, $8.6 billion in Q1 2026, and $8.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.91 Bn | 632.15 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 469.40 Bn | 462.83 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 375.75 Bn | 368.61 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 303.13 Bn | 295.44 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Astrazeneca | 257.65 Bn | 252.75 Bn | 12.86 Bn | 29.49 Bn |
| 6 | Amgen | 236.26 Bn | 222.27 Bn | 7.24 Bn | 62.75 Bn |
| 7 | Gilead Sciences | 182.12 Bn | 178.95 Bn | 6.22 Bn | 28.66 Bn |
| 8 | Pfizer | 159.46 Bn | 147.76 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Gsk | 106.21 Bn | 102.04 Bn | 8.24 Bn | -25.96 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 8.63 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.63 Bn |
| Mar 31, 2026 | 8.59 Bn |
| Dec 31, 2025 | 8.64 Bn |
| Sep 30, 2025 | 8.83 Bn |
| Jun 30, 2025 | 9.01 Bn |
| Mar 31, 2025 | 8.98 Bn |
| Dec 31, 2024 | 8.88 Bn |
| Sep 30, 2024 | 8.76 Bn |
| Jun 30, 2024 | 8.67 Bn |
| Mar 31, 2024 | 8.72 Bn |
| Dec 31, 2023 | 8.76 Bn |
| Sep 30, 2023 | 8.65 Bn |
| Jun 30, 2023 | 8.73 Bn |
| Mar 31, 2023 | 8.71 Bn |
| Dec 31, 2022 | 8.92 Bn |
| Sep 30, 2022 | 8.71 Bn |
| Jun 30, 2022 | 8.90 Bn |
| Mar 31, 2022 | 9.10 Bn |
| Dec 31, 2021 | 9.14 Bn |
| Sep 30, 2021 | 9.34 Bn |